GlassScriptPhysician profile
John A Sielatycki
NPI 1629335658
$17,115.61
in general payments reported to CMS, 2019-2025
13 companies · $511 in 2025
The $511 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,804 · 2020: $1,105 · 2021: $10K · 2022: $728 · 2023: $77.63 · 2024: $1,606 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,354 · Travel and Lodging: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,354.07 |
| Travel and Lodging | $840.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,102.48 | 2021-2024 | Unid_pass |
| Stryker Corporation | $3,444.81 | 2019-2022 | |
| Centinel Spine, LLC | $1,216.69 | 2021-2025 | Prodisc L, Prodisc C Sk, Prodisc C Nova |
| Medtronic USA, INC. | $1,088.04 | 2019-2020 | |
| Smoky Mountain Surgical LLC | $826.33 | 2024 | |
| Arthrex, INC. | $204.95 | 2024 | |
| Boston Scientific Corporation | $69.15 | 2025 | Intracept |
| Aesculap Implant Systems, LLC | $60.00 | 2020 | |
| Spineart USA INC | $32.04 | 2021 | |
| Bioventus LLC | $27.41 | 2019 | |
| Ossur Americas, INC. | $25.23 | 2025 | Unloader One X |
| Assertio Therapeutics, INC. | $18.48 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sielatycki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.